These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15802124)

  • 1. Calculating the probability of detection for inhibitors in enzymatic or binding reactions in high-throughput screening.
    Buxser S; Vroegop S
    Anal Biochem; 2005 May; 340(1):1-13. PubMed ID: 15802124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining balanced conditions for inhibitor screening assays that target bisubstrate enzymes.
    Yang J; Copeland RA; Lai Z
    J Biomol Screen; 2009 Feb; 14(2):111-20. PubMed ID: 19196704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High throughput screening for glutathione S-transferase inhibitors].
    Zhang DS; Zhang TT; Li SJ; Du GH
    Yao Xue Xue Bao; 2008 Jan; 43(1):108-12. PubMed ID: 18357743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient elimination of nonstoichiometric enzyme inhibitors from HTS hit lists.
    Habig M; Blechschmidt A; Dressler S; Hess B; Patel V; Billich A; Ostermeier C; Beer D; Klumpp M
    J Biomol Screen; 2009 Jul; 14(6):679-89. PubMed ID: 19470716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a high-throughput screening data set using potency-scaled molecular similarity algorithms.
    Vogt I; Bajorath J
    J Chem Inf Model; 2007; 47(2):367-75. PubMed ID: 17300172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput screening of enzyme inhibition using an inhibitor gradient generated in a microchannel.
    Garcia E; Hasenbank MS; Finlayson B; Yager P
    Lab Chip; 2007 Feb; 7(2):249-55. PubMed ID: 17268628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining appropriate substrate conversion for enzymatic assays in high-throughput screening.
    Wu G; Yuan Y; Hodge CN
    J Biomol Screen; 2003 Dec; 8(6):694-700. PubMed ID: 14711395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid discovery of potent sulfotransferase inhibitors by diversity-oriented reaction in microplates followed by in situ screening.
    Best MD; Brik A; Chapman E; Lee LV; Cheng WC; Wong CH
    Chembiochem; 2004 Jun; 5(6):811-9. PubMed ID: 15174164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scoring ligand similarity in structure-based virtual screening.
    Zavodszky MI; Rohatgi A; Van Voorst JR; Yan H; Kuhn LA
    J Mol Recognit; 2009; 22(4):280-92. PubMed ID: 19235177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A theoretical approach to some analytical properties of heterogeneous enzymatic assays.
    Gutiérrez OA; Chavez M; Lissi E
    Anal Chem; 2004 May; 76(9):2664-8. PubMed ID: 15117213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay.
    Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW
    Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow-binding human serine racemase inhibitors from high-throughput screening of combinatorial libraries.
    Dixon SM; Li P; Liu R; Wolosker H; Lam KS; Kurth MJ; Toney MD
    J Med Chem; 2006 Apr; 49(8):2388-97. PubMed ID: 16610782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput assays for promiscuous inhibitors.
    Feng BY; Shelat A; Doman TN; Guy RK; Shoichet BK
    Nat Chem Biol; 2005 Aug; 1(3):146-8. PubMed ID: 16408018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-throughput screening of human soluble protein tyrosine phosphatase 1B inhibitors].
    Pang XB; Xie XM; Wang SB; Du GH
    Yao Xue Xue Bao; 2011 Sep; 46(9):1058-64. PubMed ID: 22121775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a scintillation proximity assay for human insulin-like growth factor-binding protein 4 compatible with inhibitor high-throughput screening.
    Khawaja XZ
    Anal Biochem; 2007 Jul; 366(1):80-6. PubMed ID: 17482135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. eHiTS-to-VMD interface application. The search for tyrosine-tRNA ligase inhibitors.
    Eitner K; Gaweda T; Hoffmann M; Jura M; Rychlewski L; Barciszewski J
    J Chem Inf Model; 2007; 47(2):695-702. PubMed ID: 17381179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput screening technologies for drug glucuronidation profiling.
    Trubetskoy O; Finel M; Trubetskoy V
    J Pharm Pharmacol; 2008 Aug; 60(8):1061-7. PubMed ID: 18644198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A miniaturized high-throughput screening assay for fucosyltransferase VII.
    Ahsen Ov; Voigtmann U; Klotz M; Nifantiev N; Schottelius A; Ernst A; Müller-Tiemann B; Parczyk K
    Anal Biochem; 2008 Jan; 372(1):96-105. PubMed ID: 17923099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.